Related content

The Role of Epithelial–Mesenchymal Transition and IGF-1R Expression in Prediction of Gefitinib Activity as the Second-Line Treatment for Advanced Nonsmall-Cell Lung Cancer

By Chen Bei   Xiao Feng   Li Baofeng   Xie Bo   Zhou Juan   Zheng Jihua   Zhang Weimin  

Cancer Investigation, Vol. 31, Iss. 7, 2013-08 ,pp. : 454-460

Informa Healthcare

Access to resources Recommend Favorite

Combined Treatment with Epimedium koreanum Nakai Extract and Gefitinib Overcomes Drug Resistance Caused by T790M Mutation in Non-Small Cell Lung Cancer Cells

By Song Jie   Zhong Rongling   Huang Houcai   Zhang Zhenhai   Ding Dongmei   Yan Hongmei   Sun E   Jia Xiaobin  

Nutrition and Cancer, Vol. 66, Iss. 4, 2014-05 ,pp. : 682-689

Routledge Ltd

Access to resources Recommend Favorite

Integrin β1mediated acquired gefitinib resistance in nonsmall cell lung cancer cells occurs via the phosphoinositide 3-kinasedependent pathway

By            

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 535-542

Spandidos Publications

Access to resources Recommend Favorite

Selective Cytotoxicity and Combined Effects of Camptothecin or Paclitaxel with Sodium-R-Alpha Lipoate on A549 Human Non-Small Cell Lung Cancer Cells

By Ibrahim Sherif   Gao Dayuan   Sinko Patrick J.  

Nutrition and Cancer, Vol. 66, Iss. 3, 2014-04 ,pp. : 492-499

Routledge Ltd

Access to resources Recommend Favorite

MicroRNA106a confers cisplatin resistance in nonsmall cell lung cancer A549 cells by targeting adenosine triphosphatasebinding cassette A1

By  

Molecular Medicine Reports, Vol. 11, Iss. 1, 2015-01 ,pp. : 625-632

Spandidos Publications

Access to resources Recommend Favorite